Widely divergent opinions of their worth emerge at FDA hearings
Risk of fatal brain infection may outweigh Tysabri's benefits, study shows
Especially in combination with aspirin, ibuprofen, naproxen can trouble stomach, study finds
Researchers urge FDA to delay approval of muraglitazar
But the increase is small and may not outweigh benefits, experts say
Patients, doctors aren't taking precautions to prevent birth defects, researchers say
Public Citizen accuses drugmaker of hiding danger of popular asthma drug
But HRT should be used with caution
Props open neck arteries
Prominent physician questions quick approval of 'lifestyle' drugs
It protects against measles, mumps, rubella and chickenpox in one shot
Drug to help those with rare condition that neutralizes growth hormone
Combines two drugs in one pill
Distributors, doctors and patients must sign up to get the acne drug
To improve chances for high-risk heart attack survivors
Guidant under fire for "foot-dragging" over recalled implantable defibs
Still, FDA warns that RU-486 may be linked to rare but deadly blood infections
Dissolves quickly without water
Top cardiologists claim the maker of Natrecor is putting profits ahead of patient safety
Debate focuses on conflict-of-interest waivers for voting members
But advisers recommend new safety warning on labeling for one drug, Foradil
Change will reflect reports of sudden vision loss among users
Despite FDA concerns, Texas scientists say their study was only preliminary
Advisory panel suggests more safety data be gathered before any warnings are made
New labels that highlight psychiatric side effects will be ordered for one class of medicines
BiDil endorsed in milestone move by FDA
When patient complains of chest pain
Derived from tetracycline family
Treats sinusitis, pneumonia
New use for drug originally designed to treat diabetic pain
Boosts older shots that may have worn off
Rare condition can destroy heart
May benefit up to 8 million Americans
Compelling urge to move legs, often during sleep
Also protects against tetanus and diphtheria
Gila monster derivative helps manage blood sugar
Patients should have more say in treatment decisions, some experts say
Study finds consumption can lower chances of disease by as much as 22%
Use nesiritide only as "last resort," researchers say
Kills bacteria that cause gum inflammation
Herb's safety and FDA's power to regulate it at issue, experts say
Non-cox-2 painkiller plus an acid-reducer is safer and cheaper, study finds
FDA says it's evaluating the ruling before deciding whether to appeal
Debate surrounds decision to choose one product over another
Also lets doctors monitor self care
Second company persuasive in saying newer implants are safer
Some believe the decision to use the drug should stay with physicians
Guards against fluid leakage from incision
Move follows FDA concerns about drug's health risks
For people age 12 and older